Literature DB >> 19487532

Surgical management of metastatic bone disease.

Jacob Bickels1, Shlomo Dadia, Zvi Lidar.   

Abstract

Metastatic bone disease is a major contributor to the deterioration of the quality of life of patients with cancer; it causes pain, impending and actual pathological fractures, and loss of function and may also be associated with considerable metabolic alterations. Operative treatment may be required for an impending or existing fracture and intractable pain. The goals of surgery are to provide local tumor control and allow immediate weight-bearing and function. Radiation therapy is often indicated postoperatively. Detailed preoperative evaluation is required to assess the local extent of bone destruction and soft-tissue involvement, involvement of other skeletal sites, and the overall medical and oncological status.

Entities:  

Mesh:

Year:  2009        PMID: 19487532     DOI: 10.2106/JBJS.H.00175

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  45 in total

Review 1.  Outcome of operative treatment of metastatic fractures of the humerus: a systematic review of twenty three clinical studies.

Authors:  Stein J Janssen; Teun Teunis; Francis J Hornicek; Jos A M Bramer; Joseph H Schwab
Journal:  Int Orthop       Date:  2014-11-16       Impact factor: 3.075

Review 2.  [Prognosis scores for spinal metastases].

Authors:  N H von der Höh; J Gulow; S K Tschöke; A Völker; C E Heyde
Journal:  Orthopade       Date:  2013-09       Impact factor: 1.087

3.  Are Allogeneic Blood Transfusions Associated With Decreased Survival After Surgery for Long-bone Metastatic Fractures?

Authors:  Stein J Janssen; Yvonne Braun; John E Ready; Kevin A Raskin; Marco L Ferrone; Francis J Hornicek; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2015-01-31       Impact factor: 4.176

4.  What Is the Adverse Event Profile After Prophylactic Treatment of Femoral Shaft or Distal Femur Metastases?

Authors:  Ryan P McLynn; Nathaniel T Ondeck; Jonathan N Grauer; Dieter M Lindskog
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

5.  Risk factors for same-admission mortality after pathologic fracture secondary to metastatic cancer.

Authors:  Nicole K Behnke; Dustin K Baker; Shin Xu; Thomas E Niemeier; Shawna L Watson; Brent A Ponce
Journal:  Support Care Cancer       Date:  2016-10-04       Impact factor: 3.603

6.  Treatment of spinal epidural compression due to hematological malignancies: a single institution's retrospective experience.

Authors:  Charles-Henri Flouzat-Lachaniette; Jérôme Allain; Françoise Roudot-Thoraval; Alexandre Poignard
Journal:  Eur Spine J       Date:  2012-11-10       Impact factor: 3.134

7.  External Beam Irradiation Preferentially Inhibits the Endochondral Pathway of Fracture Healing: A Rat Model.

Authors:  Yongren Wu; E Lex Hanna; Robert E Holmes; Zilan Lin; Alexander M Chiaramonti; Russell A Reeves; Daniel G McDonald; Kenneth N Vanek; William R Barfield; Hai Yao; Vincent D Pellegrini
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

8.  Intramedullary nailing of femoral diaphyseal metastases: is it necessary to protect the femoral neck?

Authors:  Bryan Moon; Patrick Lin; Robert Satcher; Justin Bird; Valerae Lewis
Journal:  Clin Orthop Relat Res       Date:  2014-11-26       Impact factor: 4.176

9.  Prophylactic stabilization for bone metastases, myeloma, or lymphoma: do we need to protect the entire bone?

Authors:  Hasham M Alvi; Timothy A Damron
Journal:  Clin Orthop Relat Res       Date:  2012-10-27       Impact factor: 4.176

10.  Finite element analysis and CT-based structural rigidity analysis to assess failure load in bones with simulated lytic defects.

Authors:  Lorenzo Anez-Bustillos; Loes C Derikx; Nico Verdonschot; Nathan Calderon; David Zurakowski; Brian D Snyder; Ara Nazarian; Esther Tanck
Journal:  Bone       Date:  2013-10-18       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.